Guidelines for the Diagnosis and Treatment of Primary Osteoporosis” (2022) Interpretation Meeting
Rocaltrol® City Tour·Hangzhou Station
On July 15, 2023, the fourth stop of the “Guidelines for the Diagnosis and Treatment of Primary Osteoporosis” (2022) Interpretation Meeting and Rocaltrol® City Tour” jointly organized by Pharmanovia & Hesena was successfully held at the Hangzhou Friendship Hotel. The original intention of the “City Tour” activity is to enhance the guiding role of the “Guidelines” for clinicians and promote the whole society to pay attention to the prevention and treatment of osteoporosis. We hope to use this activity to assist the Osteoporosis and Bone Mineral Disease Branch of the Chinese Medical Association to jointly Promote the standardized diagnosis and treatment of osteoporosis, strengthen the linkage between hospitals and doctors at all levels, and improve the treatment and rehabilitation of osteoporotic fractures.
The meeting agenda was set around the “Guidelines for the Diagnosis and Treatment of Primary Osteoporosis” (2022), and Professor Li Weixu, chairman of the Professional Committee of Osteoporosis and Bone Mineral Diseases of Zhejiang Medical Association, and the director-designate of Zhejiang Professional Committee of Osteoporosis were invited Committee member Professor Yang Lei and two professors presided over the meeting, and three speakers with rich clinical experience gave you a detailed introduction to the relevant content of the diagnosis and treatment in the new version of the guideline, highlighting the sharing of the “Guidelines for the Diagnosis and Treatment of Primary Osteoporosis” ( 2022) updated content, sorting out the important role of Rocaltrol in the field of osteoporosis. At the same time, eight experts in the field of osteoporosis communicated with each other in the meeting, sharing hot information and treatment concepts of osteoporosis treatment. It fully embodies the purpose of “city meeting” to build a communication platform for doctors and promote the linkage between departments and hospitals.
After the meeting started, Professor Li Weixu first thanked all the participants for attending the meeting in spite of their busy schedules, and also thanked Pharmanovia & Hesenna for their continuous attention to the field of osteoporosis treatment. At the same time, he mentioned that Hesenna is a local pharmaceutical company in Zhejiang. Then, Professor Ying Qifeng from Zhejiang Provincial People’s Hospital was invited to introduce the diagnosis and differential diagnosis of osteoporosis to the participating experts. Through the wonderful sharing of the guidelines, he pointed out the updated content, which provided a lot of diagnosis and differential diagnosis for the doctors present. New ideas for diagnosis. It is also proposed that patients with low back pain, general pain, hyperthyroidism, hyperparathyroidism, diabetes and other diseases should do bone density screening as soon as possible, and seek medical treatment as soon as possible if problems are found. After the content, three experts, Prof. Chen Jianming from the Sixth Hospital of Ningbo, Prof. Shi Xiaolin from the Second Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine, and Prof. Xu Sanzhong from the First Affiliated Hospital of Zhejiang University School of Medicine, conducted a discussion. It is necessary to carefully inquire about the basic situation of the patients before taking the medicine, and they are very good about the hierarchical management of the new version of the guidelines. For young doctors, you can compare the changes between the previous guidelines and the new version.
The second topic of the meeting was Professor Hong Dun, member of the Standing Committee of Zhejiang Osteoporosis and Osteopathy Branch and vice president of Taizhou Hospital Orthopedics Branch. Professor Hong Dun gave an in-depth introduction to the main drugs for the prevention and treatment of osteoporosis. In particular, the effect of active vitamin D (Rocaltrol) on bone density was mentioned when supplementing the basic bone health supplement vitamin D in the basic measures. The safety of active vitamin D (Rocaltrol) has also been approved, and it can improve muscle strength and reduce the risk of falls. After the content, three experts, Professor Bian Pingda from Zhejiang Provincial People’s Hospital, Professor Wan Shuanglin from Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine, and Professor Fei Jun from Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine, conducted discussions. Patients need to have certain outdoor activities during the treatment period. Patient compliance with drug treatment is very important. At the same time, regular monitoring is required. Doctors must do a good job in patient education.
The third topic is the deputy chairman of the third Zhejiang Medical Association Osteoporosis and Bone Mineral Disease Branch, the executive deputy director of the Ningbo Osteoporosis Prevention and Treatment Clinical Guidance Center, and the Chinese Osteoporosis Expert Committee of the International Bone Densitometry Society Professor Fei Jinping of Ningbo Huamei Hospital, University of Chinese Academy of Sciences, as an expert in nephrology, mentioned that Rocaltrol is very safe and effective, with a wide range of indications, and is recommended by multinational guidelines. Osteoporosis caused by rheumatic immune diseases should be treated as early as possible. After the session, two experts, Professor Qiu Xiaohui from Li Huili Hospital of Ningbo Medical Center and Professor Zhao Xiaofeng from Shaoxing People’s Hospital, had a discussion.
The last content is the introduction of the Linglong AI Bone Densitometer by Hesenna Company, and at the same time, the engineer of the instrument was invited to give guidance. After the meeting, Prof. Fei Jinping, Prof. Ying Qifeng, and Prof. Wan Shuanglin tested the bone density together, saying that the detection speed is very fast.
Professor Yang Lei presided over the final discussion session. Many experts discussed the problems encountered in their clinical practice. Professor Yang Lei once again emphasized that Rocaltrol(calcitriol ) capsules are an indispensable therapeutic drug in the treatment of osteoporosis . It is widely used in orthopedics, endocrinology, nephrology, geriatrics, rheumatology, etc. It is of German quality and has been on the market in China for 30 years.
